Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
Clinical trial NCT05209256 · UNKNOWN
Trial details
- NCT number
- NCT05209256
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-01-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.